<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">29511</article-id><article-id pub-id-type="doi">10.7554/eLife.29511</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Targeting posttranslational modifications of RIOK1 inhibits the progression of colorectal and gastric cancers</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-94136"><name><surname>Hong</surname><given-names>Xuehui</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94137"><name><surname>Huang</surname><given-names>He</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-104759"><name><surname>Qiu</surname><given-names>Xingfeng</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94138"><name><surname>Ding</surname><given-names>Zhijie</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94139"><name><surname>Feng</surname><given-names>Xing</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94140"><name><surname>Zhu</surname><given-names>Yuekun</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94141"><name><surname>Zhuo</surname><given-names>Huiqin</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94142"><name><surname>Hou</surname><given-names>Jingjing</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-104492"><name><surname>Zhao</surname><given-names>Jiabao</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94143"><name><surname>Cai</surname><given-names>Wangyu</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-104493"><name><surname>Sha</surname><given-names>Ruihua</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94144"><name><surname>Hong</surname><given-names>Xinya</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-104494"><name><surname>Li</surname><given-names>Yongxiang</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-94145"><name><surname>Song</surname><given-names>Hongjiang</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-87674"><name><surname>Zhang</surname><given-names>Zhiyong</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8576-1607</contrib-id><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Longju Medical Research Center</institution>, <institution>Zunyi Medical College</institution>, <addr-line><named-content content-type="city">Zunyi</named-content></addr-line>, <country>China</country></aff><aff id="aff2"><institution content-type="dept">Department of Histology and Embryology</institution>, <institution>Xiangya School of Medicine</institution>, <addr-line><named-content content-type="city">Changsha</named-content></addr-line>, <country>China</country></aff><aff id="aff3"><institution content-type="dept">Department of Gastrointestinal Surgery</institution>, <institution>Zhongshan Hospital of Xiamen University</institution>, <addr-line><named-content content-type="city">Xiamen</named-content></addr-line>, <country>China</country></aff><aff id="aff4"><institution content-type="dept">Department of Radiation Oncology, Cancer Institute of New Jersey</institution>, <institution>Rutgers University</institution>, <addr-line><named-content content-type="city">New Brunswick</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Department of General Surgery</institution>, <institution>The First Affiliated Hospital of Harbin Medical University</institution>, <addr-line><named-content content-type="city">Harbin</named-content></addr-line>, <country>China</country></aff><aff id="aff6"><institution content-type="dept">Department of Digestive Disease</institution>, <institution>Hongqi Hospital, Mudanjiang Medical University</institution>, <addr-line><named-content content-type="city">Mudangjiang</named-content></addr-line>, <country>China</country></aff><aff id="aff7"><institution content-type="dept">Department of Medical Imaging and Ultrasound</institution>, <institution>Zhongshan Hospital of Xiamen University</institution>, <addr-line><named-content content-type="city">Xiamen</named-content></addr-line>, <country>China</country></aff><aff id="aff8"><institution content-type="dept">Department of General Surgery</institution>, <institution>The First Affiliated Hospital of Anhui Medical University</institution>, <addr-line><named-content content-type="city">Anhui</named-content></addr-line>, <country>China</country></aff><aff id="aff9"><institution content-type="dept">Department of General Surgery</institution>, <institution>The Third Affiliated Hospital of Harbin Medical University</institution>, <addr-line><named-content content-type="city">Harbin</named-content></addr-line>, <country>China</country></aff><aff id="aff10"><institution content-type="dept">Department of Surgery, Robert-Wood-Johnson Medical School University Hospital</institution>, <institution>Rutgers University</institution>, <addr-line><named-content content-type="city">New Brunswick</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1016"><name><surname>Hunter</surname><given-names>Tony</given-names></name><role>Reviewing editor</role><aff><institution>Salk Institute for Biological Studies</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>yongxiangli2001@outlook.com</email> (YL);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>hongjiangsong2015@163.com</email> (HS);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>zhiyongzhang@yahoo.com</email> (ZZ);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>31</day><month>01</month><year>2018</year></pub-date><volume>7</volume><elocation-id>e29511</elocation-id><history><date date-type="received"><day>10</day><month>06</month><year>2017</year></date><date date-type="accepted"><day>26</day><month>01</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Hong et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Hong et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-29511-v1.pdf"/><abstract><p>RIOK1 has recently been shown to play important roles in cancers, but its posttranslational regulation is largely unknown. Here we report that RIOK1 is methylated at K411 by SETD7 methyltransferase and that lysine-specific demethylase 1 (LSD1) reverses its methylation. The mutated RIOK1 (K411R) that cannot be methylated exhibits a longer half-life than does the methylated RIOK1. FBXO6 specifically interacts with K411-methylated RIOK1 through its FBA domain to induce RIOK1 ubiquitination. Casein kinase 2 (CK2) phosphorylates RIOK1 at T410, which stabilizes RIOK1 by antagonizing K411 methylation and impeding the recruitment of FBXO6 to RIOK1. Functional experiments demonstrate the RIOK1 methylation reduces the tumor growth and metastasis in mice model. Importantly, the protein levels of CK2 and LSD1 show an inverse correlation with FBXO6 and SETD7 expression in human colorectal cancer tissues. Together, this study highlights the importance of a RIOK1 methylation-phosphorylation switch in determining colorectal and gastric cancer development.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81602149</award-id><principal-award-recipient><name><surname>Hong</surname><given-names>Xuehui</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003392</institution-id><institution>Natural Science Foundation of Fujian Province</institution></institution-wrap></funding-source><award-id>2016J01619</award-id><principal-award-recipient><name><surname>Hong</surname><given-names>Xuehui</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experiments were performed in accordance with NIH guidelines for the use of experimental animals. Male  nonobese/severe combined immunodeficiency (NOD/SCID) mice  between 4 and 6 weeks of age, obtained from the Experimental Animal Center of Shanghai Institute for Biological Sciences (SIBS). All animal work was conducted according to Institutional Animal Care Guidelines, and all animal experiments were approved by the ethical committee of the Harbin Medical University (Protocol Number: 20150619).</p></fn><fn fn-type="other"><p>Human subjects: All human materials were obtained with informed consent and approved by the ethics committee of Hospital of Harbin Medical University (Protocol Number: 20150526).</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-29511-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>